Background Postpartum haemorrhage (PPH)‐heaving bleeding within the first 24 hours after
giving birth‐is one of the main causes of death of women after childbirth. Antifibrinolytics …

Tranexamic acid reduces bleeding by inhibiting the breakdown of blood clots. It is cost-
effective and heat-stable with a long shelf life. In the WOMAN trial, tranexamic acid reduced …

Background Post-partum haemorrhage (PPH) is a leading cause of maternal death
worldwide. The WOMAN trial assessed the effects of tranexamic acid (TXA) on death and …

Background: Postpartum haemorrhage (PPH) is a leading cause of maternal death. The
WOMAN trial showed that tranexamic acid (TXA) reduces death due to bleeding in women …

Aim Tranexamic acid (TXA) has been used to treat peripartum hemorrhage, while
preoperative use of TXA in cesarean section (CS) remains controversial. To assess the …

Viscoelastic haemostatic assays provide rapid testing at the bed‐side that identify all phases
of haemostasis, from initial fibrin formation to clot lysis. In obstetric patients, altered …

Background Postpartum hemorrhage is the leading cause of maternal death. Recently, the
WOMAN trial showed that early administration of tranexamic acid leads to a reduced …

Introducción: la hemorragia obstétrica es una de las principales causas de muerte materna
en el mundo. Reconocidos grupos de estudio a nivel mundial han recomendado identificar …

Introduction: obstetric hemorrhage is one of the main causes of maternal death in the world.
The main study groups worldwide have recommended early identification of risk factors and …

Figure 1.5: The figure represents a comparison between 2D and 3D cell culture. A
represents a 2D culture that is coated with protein, and B is a 3D culture on a scaffold. As …